APA (7th ed.) Citation

MK, P., S, B., C, G., P, H., YE, K., K, N., . . . CM, F. (2026). Advancing nonclinical blood pressure assessment: Current practices and future directions in drug development. Regulatory toxicology and pharmacology : RTP, 169, 106098. https://doi.org/10.1016/j.yrtph.2026.106098

Chicago Style (17th ed.) Citation

MK, Pugsley, et al. "Advancing Nonclinical Blood Pressure Assessment: Current Practices and Future Directions in Drug Development." Regulatory Toxicology and Pharmacology : RTP 169 (2026): 106098. https://doi.org/10.1016/j.yrtph.2026.106098.

MLA (9th ed.) Citation

MK, Pugsley, et al. "Advancing Nonclinical Blood Pressure Assessment: Current Practices and Future Directions in Drug Development." Regulatory Toxicology and Pharmacology : RTP, vol. 169, 2026, p. 106098, https://doi.org/10.1016/j.yrtph.2026.106098.